ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.677,87
-0,45%
S&P 500
5.306,04
0,02%
Dow Jones
38.852,86
-0,55%
Euro vs US Dollar
1,08462
-0,07%
Bitcoin
68.677,12
0,57%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Greenwich LifeSciences Inc (GLSI)

  7. Greenwich LifeSciences Inc (GLSI) News

GLSI

Greenwich LifeSciences (GLSI)

Greenwich LifeSciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:GLSI
DatumZeitQuelleÜberschriftSymbolFirma
20/05/202422h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GLSIGreenwich LifeSciences Inc
15/05/202422h30Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:GLSIGreenwich LifeSciences Inc
13/03/202411h00GlobeNewswire Inc.Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025NASDAQ:GLSIGreenwich LifeSciences Inc
12/03/202411h00GlobeNewswire Inc.Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in EuropeNASDAQ:GLSIGreenwich LifeSciences Inc
07/03/202415h41Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:GLSIGreenwich LifeSciences Inc
07/03/202412h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GLSIGreenwich LifeSciences Inc
06/03/202412h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GLSIGreenwich LifeSciences Inc
27/02/202412h00GlobeNewswire Inc.Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European CountriesNASDAQ:GLSIGreenwich LifeSciences Inc
22/02/202412h00GlobeNewswire Inc.Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European RegulatorsNASDAQ:GLSIGreenwich LifeSciences Inc
21/02/202412h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GLSIGreenwich LifeSciences Inc
20/02/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GLSIGreenwich LifeSciences Inc
20/02/202412h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GLSIGreenwich LifeSciences Inc
14/02/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GLSIGreenwich LifeSciences Inc
14/02/202412h00GlobeNewswire Inc.Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01NASDAQ:GLSIGreenwich LifeSciences Inc
15/12/202322h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GLSIGreenwich LifeSciences Inc
21/11/202312h00GlobeNewswire Inc.Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024NASDAQ:GLSIGreenwich LifeSciences Inc
14/11/202312h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GLSIGreenwich LifeSciences Inc
07/11/202312h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GLSIGreenwich LifeSciences Inc
30/10/202311h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GLSIGreenwich LifeSciences Inc
27/10/202312h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GLSIGreenwich LifeSciences Inc
25/10/202322h15Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GLSIGreenwich LifeSciences Inc
19/10/202322h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GLSIGreenwich LifeSciences Inc
12/10/202312h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GLSIGreenwich LifeSciences Inc
05/10/202312h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GLSIGreenwich LifeSciences Inc
21/09/202312h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GLSIGreenwich LifeSciences Inc
13/09/202312h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GLSIGreenwich LifeSciences Inc
24/08/202312h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GLSIGreenwich LifeSciences Inc
21/08/202322h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GLSIGreenwich LifeSciences Inc
14/08/202323h16Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:GLSIGreenwich LifeSciences Inc
08/08/202312h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GLSIGreenwich LifeSciences Inc
 Showing the most relevant articles for your search:NASDAQ:GLSI

Kürzlich von Ihnen besucht

OKEX
ICXETH
NASDAQ
XAAAX
PGIM Private Real Estate...
LSE
BIOT
L&g Pharma
EU
2262T
2262T
COIN
VERSBTC
BTRX
MLNBTC
BOV
ITUBR291
ITUBR291 Ex:27,75
EU
E467S
E467S
LATK
SOFAUSDT
SOFA Network
EU
SAPA
State Street Global Advi...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten